KREJČÍ, Denisa, Matěj KAROLYI, Lucie PEHALOVÁ, Jakub ŠČAVNICKÝ, Michaela ZAPLETALOVÁ, Ivana KATINOVÁ, Jaroslav ŠTĚRBA, Jan STARY, Lenka ŠNAJDROVÁ, Martin KOMENDA a Ladislav DUŠEK. Development of the Czech Childhood Cancer Information System: Data Analysis and Interactive Visualization. JMIR PUBLIC HEALTH AND SURVEILLANCE. TORONTO: JMIR PUBLICATIONS, INC, 2021, roč. 7, č. 6, s. 1-9. ISSN 2369-2960. Dostupné z: https://dx.doi.org/10.2196/23990.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Development of the Czech Childhood Cancer Information System: Data Analysis and Interactive Visualization
Autoři KREJČÍ, Denisa (203 Česká republika, garant, domácí), Matěj KAROLYI (203 Česká republika, domácí), Lucie PEHALOVÁ (203 Česká republika, domácí), Jakub ŠČAVNICKÝ (703 Slovensko, domácí), Michaela ZAPLETALOVÁ (203 Česká republika, domácí), Ivana KATINOVÁ (203 Česká republika, domácí), Jaroslav ŠTĚRBA (203 Česká republika, domácí), Jan STARY (203 Česká republika), Lenka ŠNAJDROVÁ (203 Česká republika, domácí), Martin KOMENDA (203 Česká republika, domácí) a Ladislav DUŠEK (203 Česká republika, domácí).
Vydání JMIR PUBLIC HEALTH AND SURVEILLANCE, TORONTO, JMIR PUBLICATIONS, INC, 2021, 2369-2960.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30304 Public and environmental health
Stát vydavatele Kanada
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 14.557
Kód RIV RIV/00216224:14110/21:00123835
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.2196/23990
UT WoS 000738510300007
Klíčová slova anglicky cancer epidemiology; children; data visualization; software development
Štítky 14110321, 14119612, podil, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 9. 3. 2022 12:36.
Anotace
Background: The knowledge of cancer burden in the population, its time trends, and the possibility of international comparison is an important starting point for cancer programs. A reliable interactive tool describing cancer epidemiology in children and adolescents has been nonexistent in the Czech Republic until recently. Objective: The goal of this study is to develop a new web portal entitled the Czech Childhood Cancer Information System (CCCIS), which would provide information on childhood cancer epidemiology in the Czech Republic. Methods: Data on childhood cancers have been obtained from the Czech National Cancer Registry. These data were validated using the clinical database of childhood cancer patients and subsequently combined with data from the National Register of Hospitalised Patients and with data from death certificates. These validated data were then used to determine the incidence and survival rates of childhood cancer patients aged 0 to 19 years who were diagnosed in the period 1994 to 2016 (N=9435). Data from death certificates were used to monitor long-term mortality trends. The technical solution is based on the robust PHP development Symfony framework, with the PostgreSQL system used to accommodate the data basis. Results: The web portal has been available for anyone since November 2019, providing basic information for experts (ie, analyses and publications) on individual diagnostic groups of childhood cancers. It involves an interactive tool for analytical reporting, which provides information on the following basic topics in the form of graphs or tables: incidence, mortality, and overall survival. Feedback was obtained and the accuracy of outputs published on the CCCIS portal was verified using the following methods: the validation of the theoretical background and the user testing. Conclusions: We developed software capable of processing data from multiple sources, which is freely available to all users and makes it possible to carry out automated analyses even for users without mathematical background; a simple selection of a topic to be analyzed is required from the user.
Návaznosti
MUNI/A/1701/2020, interní kód MUNázev: Personalizovaná léčba v dětské onkologii: na cestě k „liquid dynamic medicine“ a „N-of-1 clinical trials“
Investor: Masarykova univerzita, Personalizovaná léčba v dětské onkologii: na cestě k „liquid dynamic medicine“ a „N-of-1 clinical trials“
VytisknoutZobrazeno: 16. 7. 2024 20:29